Jason Weber

Medicine & Life Sciences

1. nucleophosmin 100%
2. Neoplasms 77%
3. Ribosomes 65%
4. Growth 51%
5. Proteins 46%
6. Breast Neoplasms 42%
7. TOR Serine-Threonine Kinases 39%
8. Retinoblastoma Protein 35%
9. Triple Negative Breast Neoplasms 35%
10. Cell Proliferation 34%
11. Fibroblasts 34%
12. Cyclin D1 34%
13. Cell Cycle Checkpoints 33%
14. Phosphatidylinositol 3-Kinase 32%
15. Protein Biosynthesis 31%
16. RNA Helicases 30%
17. Tumor Suppressor Proteins 29%
18. Cell Nucleus Active Transport 25%
19. Cell Cycle 24%
20. Embryonic Structures 21%
21. Synthetic Lethal Mutations 21%
22. Neurofibromin 1 21%
23. Mechanistic Target of Rapamycin Complex 1 20%
24. Neurofibromatosis 1 20%
25. Apoptosis 19%
26. Carcinogenesis 19%
27. Mitogen-Activated Protein Kinase 3 19%
28. Mutation 18%
29. Cell Line 17%
30. Oncogene Proteins 17%
31. Estrogen Receptors 17%
32. Messenger RNA 16%
33. Ribosomal DNA 16%
34. Astrocytes 15%
35. Phosphorylation 15%
36. Oncogenes 15%
37. Proteomics 15%
38. Therapeutics 15%
39. Glioma 14%
40. Genes 14%
41. Osteoclasts 14%
42. G1 Phase 14%
43. Tumor Suppressor Protein p14ARF 14%
44. Polyribosomes 14%
45. ribosomal protein L5 13%
46. 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine 13%
47. Tuberous Sclerosis 13%
48. Cellular Senescence 12%
49. Platelet-Derived Growth Factor 12%